PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12515593-4	2002	Although PB treatment resulted in a significant elevation in CYP2B, CYP2C11, and CYP3A levels, only CYP3A levels were significantly increased by DEX treatment.	Phenobarbital	9-11	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	68-75	
12515593-4	2002	Although PB treatment resulted in a significant elevation in CYP2B, CYP2C11, and CYP3A levels, only CYP3A levels were significantly increased by DEX treatment.	Phenobarbital	9-11	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	81-86	
12515593-4	2002	Although PB treatment resulted in a significant elevation in CYP2B, CYP2C11, and CYP3A levels, only CYP3A levels were significantly increased by DEX treatment.	Dexamethasone	145-148	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	100-105	
12515593-6	2002	SKF 525A, which inhibits CYP2B, CYP2C11, and CYP3A2, and orphenadrine, which inhibits CYP2B, also decreased MA(2) formation in liver microsomes from 7-wk-old phenobarbital-pretreated rats.	Proadifen	0-8	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	32-39	
12515593-6	2002	SKF 525A, which inhibits CYP2B, CYP2C11, and CYP3A2, and orphenadrine, which inhibits CYP2B, also decreased MA(2) formation in liver microsomes from 7-wk-old phenobarbital-pretreated rats.	Proadifen	0-8	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	45-51	
12515593-8	2002	Furthermore, an immunoinhibition study demonstrated that anti-CYP3A2 antibody reduced MA(1), MAX, and MA(2) formation to nondetectable levels in liver microsomes from 2- and 7-wk-old rats, whereas anti-CYP2C11 or anti-CYP2B antibody, respectively, had no marked effect on MA(1), MAX, and MA(2) formation in liver microsomes from 7-wk-old untreated or PB-treated rats.	Phenobarbital	351-353	cytochrome P450, family 3, subfamily a, polypeptide 2	Rattus norvegicus	62-68